Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSpotting a small air bubble in a semaglutide syringe is one of the most common concerns people raise at the point of injection — and in almost every case, it is harmless. A subcutaneous injection delivers medicine into fatty tissue just beneath the skin, not into a vein, so a tiny bubble poses no medical danger. That said, a large bubble can displace dose, which is worth understanding before you press the plunger. Semaglutide (Wegovy) is a once-weekly prescription weight-loss injection reviewed and issued by a registered prescriber; if anything about your injection technique concerns you, your clinical team is the right first call.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It happens to almost everyone at some point. You draw up the semaglutide dose, hold the syringe up to the light, and there it is, a pale, wobbly pocket of air floating near the needle end. Your first instinct is probably concern. Is the dose still correct? Is it safe to inject?
The reassuring answer, backed by standard clinical guidance, is that a small air bubble in a subcutaneous injection is not a medical emergency. Subcutaneous injections are delivered into the layer of fatty tissue just under the skin, the abdomen, outer thigh, or upper arm. Unlike intravenous injections, which go directly into a bloodstream, subcutaneous ones do not create a path for air to reach the circulation in any clinically significant way. The NHS patient information for semaglutide confirms that self-injection technique centres on consistent site rotation and a clean, controlled plunger press, not on achieving a perfectly bubble-free barrel.
Where a bubble does become worth addressing is size. A bubble occupying more than roughly 1–2 mm of the syringe barrel can displace enough liquid to reduce your actual dose. If you are drawing up from a vial rather than using a pre-filled pen, it is worth developing a habit of clearing bubbles before every injection, not out of fear, but out of precision.
One small, practical note: storing your syringe horizontally in a cool place, rather than needle-down in a bag, reduces the chance of a larger bubble forming before you even begin.
The technique is straightforward and takes about ten seconds once you know it. After drawing up your dose, keep the needle capped and hold the syringe with the needle pointing upward. Tap the barrel firmly but lightly with your fingernail, two or three quick taps usually moves the bubble toward the needle end. Then, very slowly, advance the plunger until the bubble emerges through the needle tip. Stop the moment you see liquid at the tip; any further movement wastes medicine.
Now re-read the dose marker. If the plunger has moved beyond your intended marking, the drawn-up volume is short and you will need to draw up again. This is the step most people miss, clearing the bubble without rechecking the graduation line means you might inject less than the prescribed amount. Detailed injection guidance walks through the full process, from drawing up to post-injection needle removal.
Some people find the whole sequence easier if they attach a fresh needle just before injecting, drawing up with one needle and swapping to a sterile one for the injection itself. If you replace needles each time, keeping a supply of compatible injection needles on hand makes this routine simpler. Either way, always swab the skin at the injection site beforehand.
What you do not need to do is inject an air-heavy syringe hoping the tissue will absorb the bubble safely. That approach, while not dangerous subcutaneously, does risk an inconsistent dose. A few extra seconds of prep is always the better path.
If you are using the standard pre-filled Wegovy injection pen rather than drawing up from a vial, the bubble mechanics are different. Pre-filled auto-injector pens are designed with a small dead-volume allowance and a fixed plunger mechanism. A faint air column visible through the pen's window is normal and expected, it does not represent a significant dose error, and you should not attempt to prime the pen in the same way you would clear a draw-up syringe.
That said, questions about air in a Wegovy pen are worth treating separately, because the pen's internal design means the guidance differs. Our page on air bubbles in the Wegovy pen covers exactly that. Similarly, if you are working with a syringe but drawing up from a multi-dose vial, the steps for giving a semaglutide injection with a syringe include the full priming sequence in one place.
For questions specific to needle depth (which affects how cleanly the dose disperses into the subcutaneous layer) guidance on injection depth for semaglutide explains the clinical reasoning. And if you have ever wondered whether what you are dealing with is really air or something else in the barrel, the broader question of air bubbles in semaglutide injections generally covers the full range of presentations.
Most air bubble queries have a simple answer: clear it, recheck the dose, inject. But there are situations where pausing and contacting a clinician is the right move. These include: the liquid in the syringe looks cloudy or discoloured (semaglutide should be clear and colourless to slightly yellow); you notice visible particles; you are unsure whether the pen or vial has been stored correctly (both require refrigeration at 2–8 °C, check the Patient Information Leaflet for exact handling windows); or you have already injected and are uncertain whether you received the full dose.
It is also worth speaking to your prescriber before your next injection if you have been experiencing side effects that seem more intense than expected, since dose accuracy matters for tolerability as well as effect. The MHRA's Yellow Card scheme is where any unexpected or serious side effects from semaglutide can be formally reported.
Semaglutide for weight management is a prescription medicine. The right clinical support does not stop after the prescription is written. If your current provider is not easy to reach when a practical question arises (like this one) it is reasonable to ask whether your aftercare matches what you need. You can explore how our free consultation works and what ongoing support looks like from a GPhC-registered online pharmacy.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.